应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PMN ProMIS Neurosciences Inc
已收盘 07-11 16:00:00 EDT
0.3904
-0.0121
-3.01%
盘后
0.3904
+0.0000
0.00%
19:53 EDT
最高
0.4199
最低
0.3900
成交量
14.14万
今开
0.4196
昨收
0.4025
日振幅
7.43%
总市值
1,276万
流通市值
610.11万
总股本
3,269万
成交额
5.69万
换手率
0.90%
流通股本
1,563万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Promis Neurosciences Inc.盘中异动 急速下跌5.44%报0.382美元
市场透视 · 07-09 13:34
Promis Neurosciences Inc.盘中异动 急速下跌5.44%报0.382美元
Promis Neurosciences Inc.盘中异动 早盘股价大涨6.18%
市场透视 · 07-07
Promis Neurosciences Inc.盘中异动 早盘股价大涨6.18%
Promis Neurosciences Inc.盘中异动 临近收盘大幅跳水5.86%
市场透视 · 07-02
Promis Neurosciences Inc.盘中异动 临近收盘大幅跳水5.86%
两家公司共同押注,自免新王牌即将亮剑?
Ofweek维科网 · 07-02
两家公司共同押注,自免新王牌即将亮剑?
Promis Neurosciences Inc.盘中异动 下午盘股价大跌5.50%
市场透视 · 06-23
Promis Neurosciences Inc.盘中异动 下午盘股价大跌5.50%
Promis Neurosciences Inc.盘中异动 早盘大幅下挫6.66%报0.485美元
市场透视 · 06-16
Promis Neurosciences Inc.盘中异动 早盘大幅下挫6.66%报0.485美元
Promis Neurosciences Inc.盘中异动 下午盘大幅拉升5.66%报0.528美元
市场透视 · 06-10
Promis Neurosciences Inc.盘中异动 下午盘大幅拉升5.66%报0.528美元
Promis Neurosciences Inc.股价飙升10.04% 市值涨172.64万美元
市场透视 · 06-09
Promis Neurosciences Inc.股价飙升10.04% 市值涨172.64万美元
Promis Neurosciences Inc.盘中异动 快速拉升5.72%报0.508美元
市场透视 · 06-06
Promis Neurosciences Inc.盘中异动 快速拉升5.72%报0.508美元
Promis Neurosciences Inc.盘中异动 早盘急速上涨12.16%报0.565美元
市场透视 · 06-05
Promis Neurosciences Inc.盘中异动 早盘急速上涨12.16%报0.565美元
Promis Neurosciences Inc.盘中异动 快速上涨8.20%
市场透视 · 06-03
Promis Neurosciences Inc.盘中异动 快速上涨8.20%
Promis Neurosciences Inc.盘中异动 快速下挫6.48%
市场透视 · 06-02
Promis Neurosciences Inc.盘中异动 快速下挫6.48%
Promis Neurosciences Inc.盘中异动 早盘大幅上涨8.04%报0.519美元
市场透视 · 05-29
Promis Neurosciences Inc.盘中异动 早盘大幅上涨8.04%报0.519美元
Promis Neurosciences Inc.盘中异动 快速拉升6.53%
市场透视 · 05-27
Promis Neurosciences Inc.盘中异动 快速拉升6.53%
Promis Neurosciences Inc.盘中异动 快速拉升6.98%
市场透视 · 05-23
Promis Neurosciences Inc.盘中异动 快速拉升6.98%
Promis Neurosciences Inc.盘中异动 股价大涨9.61%
市场透视 · 05-22
Promis Neurosciences Inc.盘中异动 股价大涨9.61%
Promis Neurosciences Inc.盘中异动 股价大跌6.02%
市场透视 · 05-21
Promis Neurosciences Inc.盘中异动 股价大跌6.02%
Promis Neurosciences Inc.盘中异动 股价大涨6.00%报0.530美元
市场透视 · 05-20
Promis Neurosciences Inc.盘中异动 股价大涨6.00%报0.530美元
Promis Neurosciences Inc.2025财年第一财季实现净利润-7.35百万美元,同比减少101.92%
市场透视 · 05-18
Promis Neurosciences Inc.2025财年第一财季实现净利润-7.35百万美元,同比减少101.92%
Promis Neurosciences Inc.盘中异动 股价大跌8.87%
市场透视 · 05-16
Promis Neurosciences Inc.盘中异动 股价大跌8.87%
加载更多
公司概况
公司名称:
ProMIS Neurosciences Inc
所属市场:
NASDAQ
上市日期:
--
主营业务:
ProMIS Neurosciences Inc.根据加拿大商业公司法于2004年1月23日成立,位于安大略省多伦多市央街1920号。该公司正在应用其专利技术平台,在神经退行性疾病和其他错误折叠的蛋白质疾病(包括阿尔茨海默病多系统萎缩和肌萎缩性侧索硬化症)中构建抗体疗法、治疗性疫苗和其他基于抗体的疗法组合。该公司还计划研究其他突触核蛋白病,包括帕金森病和路易体痴呆、额颞叶变性、进行性核上性麻痹、皮质基底节变性和精神分裂症。这些疾病有一个共同的生物学原因——错误折叠的蛋白质,否则会发挥正常功能,变得有毒并杀死神经元,从而导致疾病。ProMIS的技术平台是通过计算能力、计算机发现和人工智能实现药物发现进步的一个例子。
发行价格:
--
{"stockData":{"symbol":"PMN","market":"US","secType":"STK","nameCN":"ProMIS Neurosciences Inc","latestPrice":0.390401,"timestamp":1752264000000,"preClose":0.4025,"halted":0,"volume":141397,"hourTrading":{"tag":"盘后","latestPrice":0.390401,"preClose":0.390401,"latestTime":"19:53 EDT","volume":56,"amount":22.1622,"timestamp":1752277982208},"delay":0,"floatShares":15627688,"shares":32689190,"eps":-0.031393,"marketStatus":"已收盘","change":-0.012099,"latestTime":"07-11 16:00:00 EDT","open":0.4196,"high":0.4199,"low":0.39,"amount":56897.35814886,"amplitude":0.074286,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.031393,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":0.4025,"postHourTrading":{"tag":"盘后","latestPrice":0.390401,"preClose":0.390401,"latestTime":"19:53 EDT","volume":56,"amount":22.1622,"timestamp":1752277982208},"volumeRatio":1.04811},"requestUrl":"/m/hq/s/PMN","defaultTab":"news","newsList":[{"id":"2550748658","title":"Promis Neurosciences Inc.盘中异动 急速下跌5.44%报0.382美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550748658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550748658?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:34","pubTimestamp":1752068056,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时34分,Promis Neurosciences Inc.股票出现波动,股价大幅跳水5.44%。截至发稿,该股报0.382美元/股,成交量2858股,换手率0.01%,振幅1.43%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为1.09%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213416953c34d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709213416953c34d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PMN","ARFXD","ARFXF"],"gpt_icon":0},{"id":"2549606558","title":"Promis Neurosciences Inc.盘中异动 早盘股价大涨6.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549606558","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549606558?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:40","pubTimestamp":1751895644,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时40分,Promis Neurosciences Inc.股票出现波动,股价快速上涨6.18%。截至发稿,该股报0.459美元/股,成交量1.3196万股,换手率0.04%,振幅2.08%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为0.60%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707214044a43bfa0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707214044a43bfa0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","BK4139","PMN"],"gpt_icon":0},{"id":"2548817435","title":"Promis Neurosciences Inc.盘中异动 临近收盘大幅跳水5.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548817435","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548817435?lang=zh_cn&edition=full","pubTime":"2025-07-03 03:49","pubTimestamp":1751485782,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日03时49分,Promis Neurosciences Inc.股票出现异动,股价急速下挫5.86%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为1.09%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507030349429797a63d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507030349429797a63d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","ARFXD","ARFXF","BK4139"],"gpt_icon":0},{"id":"2548320668","title":"两家公司共同押注,自免新王牌即将亮剑?","url":"https://stock-news.laohu8.com/highlight/detail?id=2548320668","media":"Ofweek维科网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548320668?lang=zh_cn&edition=full","pubTime":"2025-07-02 09:16","pubTimestamp":1751418968,"startTime":"0","endTime":"0","summary":"CD38抗体自免肾病预期升温。它与CD38的结合方式经过精心设计,避免了补体介导的细胞毒性,同时保持对病理性抗体产生细胞的精准清除。超过75%的患者最终会失去移植肾,而且目前没有任何获批的治疗药物。数据预计2027年公布,如果积极,菲泽妥单抗有望成为AMR领域的first-in-class药物。根据公告,天境生物不仅与Biogen共同推进IgAN和PMN的全球三期研究,还负责这两个适应症在中国的监管沟通和上市注册工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070209173297969aa2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070209173297969aa2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","LU0320765992.SGD","LU0889565916.HKD","LU0234570918.USD","LU0109394709.USD","BIIB","IE00B894F039.SGD","PMN","BK4532","BK4533","BK4585","IE00B19Z9Z06.USD","IE00B19Z9P08.USD"],"gpt_icon":0},{"id":"2545442211","title":"Promis Neurosciences Inc.盘中异动 下午盘股价大跌5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545442211","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545442211?lang=zh_cn&edition=full","pubTime":"2025-06-24 03:26","pubTimestamp":1750706783,"startTime":"0","endTime":"0","summary":"北京时间2025年06月24日03时26分,Promis Neurosciences Inc.股票出现波动,股价大幅跳水5.50%。截至发稿,该股报0.473美元/股,成交量1.2154万股,换手率0.04%,振幅2.90%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624032624a4b9dbd9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250624032624a4b9dbd9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXD","ARFXF","PMN"],"gpt_icon":0},{"id":"2543609841","title":"Promis Neurosciences Inc.盘中异动 早盘大幅下挫6.66%报0.485美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543609841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543609841?lang=zh_cn&edition=full","pubTime":"2025-06-16 22:51","pubTimestamp":1750085505,"startTime":"0","endTime":"0","summary":"北京时间2025年06月16日22时51分,Promis Neurosciences Inc.股票出现波动,股价急速下跌6.66%。截至发稿,该股报0.485美元/股,成交量2.0349万股,换手率0.06%,振幅6.74%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.56%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616225146951ed584&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250616225146951ed584&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","BK4139","PMN","ARFXF"],"gpt_icon":0},{"id":"2542915342","title":"Promis Neurosciences Inc.盘中异动 下午盘大幅拉升5.66%报0.528美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542915342","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542915342?lang=zh_cn&edition=full","pubTime":"2025-06-11 03:19","pubTimestamp":1749583156,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日03时19分,Promis Neurosciences Inc.股票出现波动,股价快速拉升5.66%。截至发稿,该股报0.528美元/股,成交量4.3645万股,换手率0.13%,振幅9.80%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为1.03%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506110319169779c35d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506110319169779c35d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","BK4139","PMN"],"gpt_icon":0},{"id":"2542387011","title":"Promis Neurosciences Inc.股价飙升10.04% 市值涨172.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542387011","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542387011?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:32","pubTimestamp":1749475957,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时32分,Promis Neurosciences Inc.股票出现异动,股价大幅拉升10.04%。截至发稿,该股报0.526美元/股,成交量1400股,换手率0.00%,振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.55%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213237a700afa4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250609213237a700afa4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","PMN","ARFXD","BK4139"],"gpt_icon":0},{"id":"2541286240","title":"Promis Neurosciences Inc.盘中异动 快速拉升5.72%报0.508美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541286240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541286240?lang=zh_cn&edition=full","pubTime":"2025-06-07 01:32","pubTimestamp":1749231120,"startTime":"0","endTime":"0","summary":"北京时间2025年06月07日01时32分,Promis Neurosciences Inc.股票出现异动,股价急速上涨5.72%。截至发稿,该股报0.508美元/股,成交量3.4052万股,换手率0.10%,振幅3.58%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.50%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060701320095119ae2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025060701320095119ae2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","BK4139","PMN","ARFXF"],"gpt_icon":0},{"id":"2541752640","title":"Promis Neurosciences Inc.盘中异动 早盘急速上涨12.16%报0.565美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541752640","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541752640?lang=zh_cn&edition=full","pubTime":"2025-06-05 21:31","pubTimestamp":1749130274,"startTime":"0","endTime":"0","summary":"北京时间2025年06月05日21时31分,Promis Neurosciences Inc.股票出现异动,股价大幅拉升12.16%。截至发稿,该股报0.565美元/股,成交量395股,换手率0.00%,振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为0.08%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605213114a49b7f51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250605213114a49b7f51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PMN","ARFXF","ARFXD"],"gpt_icon":0},{"id":"2540054757","title":"Promis Neurosciences Inc.盘中异动 快速上涨8.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540054757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540054757?lang=zh_cn&edition=full","pubTime":"2025-06-04 00:13","pubTimestamp":1748967213,"startTime":"0","endTime":"0","summary":"北京时间2025年06月04日00时13分,Promis Neurosciences Inc.股票出现波动,股价急速拉升8.20%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.46%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604001333950d26d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250604001333950d26d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","PMN","BK4139","ARFXF"],"gpt_icon":0},{"id":"2540796813","title":"Promis Neurosciences Inc.盘中异动 快速下挫6.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2540796813","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540796813?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:38","pubTimestamp":1748871480,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时38分,Promis Neurosciences Inc.股票出现波动,股价快速下跌6.48%。截至发稿,该股报0.486美元/股,成交量3.5067万股,换手率0.11%,振幅8.27%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.93%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213800a496bda2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213800a496bda2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","BK4139","ARFXD","ARFXF"],"gpt_icon":0},{"id":"2539332264","title":"Promis Neurosciences Inc.盘中异动 早盘大幅上涨8.04%报0.519美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539332264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539332264?lang=zh_cn&edition=full","pubTime":"2025-05-29 22:36","pubTimestamp":1748529361,"startTime":"0","endTime":"0","summary":"北京时间2025年05月29日22时36分,Promis Neurosciences Inc.股票出现异动,股价急速上涨8.04%。截至发稿,该股报0.519美元/股,成交量3682股,换手率0.01%,振幅8.02%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.69%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529223601a4917d09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250529223601a4917d09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PMN","ARFXF","ARFXD"],"gpt_icon":0},{"id":"2538460307","title":"Promis Neurosciences Inc.盘中异动 快速拉升6.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2538460307","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538460307?lang=zh_cn&edition=full","pubTime":"2025-05-27 22:41","pubTimestamp":1748356877,"startTime":"0","endTime":"0","summary":"北京时间2025年05月27日22时41分,Promis Neurosciences Inc.股票出现异动,股价快速上涨6.53%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为1.20%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052722411795047481&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052722411795047481&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","ARFXD","PMN","BK4139"],"gpt_icon":0},{"id":"2537113446","title":"Promis Neurosciences Inc.盘中异动 快速拉升6.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537113446","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537113446?lang=zh_cn&edition=full","pubTime":"2025-05-23 21:33","pubTimestamp":1748007197,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日21时33分,Promis Neurosciences Inc.股票出现异动,股价急速拉升6.98%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为0.79%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213317a489c581&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213317a489c581&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PMN","BK4139","ARFXD","ARFXF"],"gpt_icon":0},{"id":"2537941025","title":"Promis Neurosciences Inc.盘中异动 股价大涨9.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537941025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537941025?lang=zh_cn&edition=full","pubTime":"2025-05-22 21:30","pubTimestamp":1747920629,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日21时30分,Promis Neurosciences Inc.股票出现异动,股价快速上涨9.61%。截至发稿,该股报0.544美元/股,成交量81股,换手率0.00%,振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213029a6e8f0e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213029a6e8f0e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXF","BK4139","ARFXD","PMN"],"gpt_icon":0},{"id":"2537934651","title":"Promis Neurosciences Inc.盘中异动 股价大跌6.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537934651","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537934651?lang=zh_cn&edition=full","pubTime":"2025-05-21 22:39","pubTimestamp":1747838355,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日22时39分,Promis Neurosciences Inc.股票出现波动,股价大幅下跌6.02%。截至发稿,该股报0.493美元/股,成交量7768股,换手率0.02%,振幅1.90%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体跌幅为0.28%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505212239169760e9a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505212239169760e9a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ARFXF","ARFXD","PMN"],"gpt_icon":0},{"id":"2536643495","title":"Promis Neurosciences Inc.盘中异动 股价大涨6.00%报0.530美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536643495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536643495?lang=zh_cn&edition=full","pubTime":"2025-05-20 21:31","pubTimestamp":1747747886,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日21时31分,Promis Neurosciences Inc.股票出现波动,股价大幅上涨6.00%。截至发稿,该股报0.530美元/股,成交量2986股,换手率0.01%,振幅0.00%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.07%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520213126a6e62294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520213126a6e62294&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","ARFXF","BK4139","PMN"],"gpt_icon":0},{"id":"2536459485","title":"Promis Neurosciences Inc.2025财年第一财季实现净利润-7.35百万美元,同比减少101.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536459485","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536459485?lang=zh_cn&edition=full","pubTime":"2025-05-19 00:00","pubTimestamp":1747584041,"startTime":"0","endTime":"0","summary":"5月19日,Promis Neurosciences Inc.公布财报,公告显示公司2025财年第一财季净利润为-7.35百万美元,同比减少101.92%;其中营业收入为0.00美元,每股基本收益为-0.21美元。从资产负债表来看,Promis Neurosciences Inc.总负债4.17百万美元,其中短期债务0.00美元,资产负债比为3.28,流动比率为3.37。机构评级:截至2025年5月19日,当前有3家机构对Promis Neurosciences Inc.目标价做出预测,其中目标均价为5.67美元,其中最低目标价为3.00美元,最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000203a6e3a73e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519000203a6e3a73e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","PMN","ARFXF"],"gpt_icon":0},{"id":"2536131088","title":"Promis Neurosciences Inc.盘中异动 股价大跌8.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536131088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536131088?lang=zh_cn&edition=full","pubTime":"2025-05-16 23:57","pubTimestamp":1747411040,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日23时57分,Promis Neurosciences Inc.股票出现异动,股价大幅下跌8.87%。截至发稿,该股报0.483美元/股,成交量7516股,换手率0.02%,振幅7.17%。Promis Neurosciences Inc.股票所在的生物技术行业中,整体涨幅为0.32%。Promis Neurosciences Inc.公司简介:ProMIS Neurosciences Inc 是一家临床阶段的生物技术公司,专注于生产和开发抗体疗法,选择性靶向阿尔茨海默病 、肌萎缩侧索硬化症 和多系统萎缩 等神经退行性疾病中的毒性错误折叠蛋白。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051623572094f92696&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051623572094f92696&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ARFXD","PMN","ARFXF","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.promisneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.0689},{"period":"1month","weight":-0.2095},{"period":"3month","weight":-0.2807},{"period":"6month","weight":-0.6092},{"period":"1year","weight":-0.8227},{"period":"ytd","weight":-0.5753}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ProMIS Neurosciences Inc.根据加拿大商业公司法于2004年1月23日成立,位于安大略省多伦多市央街1920号。该公司正在应用其专利技术平台,在神经退行性疾病和其他错误折叠的蛋白质疾病(包括阿尔茨海默病多系统萎缩和肌萎缩性侧索硬化症)中构建抗体疗法、治疗性疫苗和其他基于抗体的疗法组合。该公司还计划研究其他突触核蛋白病,包括帕金森病和路易体痴呆、额颞叶变性、进行性核上性麻痹、皮质基底节变性和精神分裂症。这些疾病有一个共同的生物学原因——错误折叠的蛋白质,否则会发挥正常功能,变得有毒并杀死神经元,从而导致疾病。ProMIS的技术平台是通过计算能力、计算机发现和人工智能实现药物发现进步的一个例子。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.298191},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.061971},{"month":3,"riseRate":0,"avgChangeRate":-0.061506},{"month":4,"riseRate":0.666667,"avgChangeRate":0.13153},{"month":5,"riseRate":0,"avgChangeRate":-0.176878},{"month":6,"riseRate":0,"avgChangeRate":-0.154013},{"month":7,"riseRate":0,"avgChangeRate":-0.157229},{"month":8,"riseRate":0,"avgChangeRate":-0.147482},{"month":9,"riseRate":0.666667,"avgChangeRate":0.006649},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.048657},{"month":11,"riseRate":0,"avgChangeRate":-0.207347},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.081121}],"exchange":"NASDAQ","name":"ProMIS Neurosciences Inc","nameEN":"ProMIS Neurosciences Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ProMIS Neurosciences Inc,PMN,ProMIS Neurosciences Inc股票,ProMIS Neurosciences Inc股票老虎,ProMIS Neurosciences Inc股票老虎国际,ProMIS Neurosciences Inc行情,ProMIS Neurosciences Inc股票行情,ProMIS Neurosciences Inc股价,ProMIS Neurosciences Inc股市,ProMIS Neurosciences Inc股票价格,ProMIS Neurosciences Inc股票交易,ProMIS Neurosciences Inc股票购买,ProMIS Neurosciences Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProMIS Neurosciences Inc(PMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ProMIS Neurosciences Inc(PMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}